Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-01-24 4:15 pm Purchase | 13G | AETHLON MED INC PAR $0.001 AEMD | ARMISTICE CAPITAL LLC | 315,648 3.8% | 315,648 (New Position) | View |
2020-01-23 4:41 pm Purchase | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH | ARMISTICE CAPITAL LLC | 1,419,507 19.9% | 1,092,060 (+333.51%) | View |
2020-01-15 4:46 pm Unchanged | 13D | EYEGATE PHARMACEUTICALS INC CO EYEG | ARMISTICE CAPITAL LLC | 3,245,000 54.1% | 0 (Unchanged) | View |
2020-01-10 4:07 pm Unchanged | 13D | EYEGATE PHARMACEUTICALS INC CO EYEG | ARMISTICE CAPITAL LLC | 3,245,000 54.1% | 0 (Unchanged) | View |
2020-01-10 4:03 pm Purchase | 13G | ONCONOVA THERAPEUTICS INC ONTX | ARMISTICE CAPITAL LLC | 7,286,201 4.99% | 1,993,893 (+37.68%) | View |
2019-12-27 5:04 pm Purchase | 13G | EKSO BIONICS HLDGS INC EKSO | ARMISTICE CAPITAL LLC | 4,356,559 4.99% | 4,356,559 (New Position) | View |
2019-12-27 4:58 pm Purchase | 13G | CAPRICOR THERAPEUTICS INC CAPR | ARMISTICE CAPITAL LLC | 243,184 4.99% | 243,184 (New Position) | View |
2019-12-23 5:15 pm Purchase | 13G | VALERITAS HLDGS INC PAR VLRX | ARMISTICE CAPITAL LLC | 924,693 9.99% | 924,693 (New Position) | View |
2019-12-20 5:00 pm Purchase | 13G | AETHLON MEDICAL INC AEMD | ARMISTICE CAPITAL LLC | 221,609 4.99% | 221,609 (New Position) | View |
2019-12-20 4:13 pm Purchase | 13G | SCYNEXIS INC SCYX | ARMISTICE CAPITAL LLC | 6,222,778 5.7% | 6,222,778 (New Position) | View |
2019-12-19 4:50 pm Purchase | 13G | ONCONOVA THERAPEUTICS INC ONTX | ARMISTICE CAPITAL LLC | 5,292,308 4.99% | 4,995,828 (+1685.05%) | View |
2019-12-19 4:46 pm Purchase | 13G | RESTORBIO INC TORC | ARMISTICE CAPITAL LLC | 3,500,000 9.6% | 3,500,000 (New Position) | View |
2019-12-13 4:21 pm Purchase | 13G | AKERS BIOSCIENCES INC N AKER | ARMISTICE CAPITAL LLC | 190,714 9.99% | 190,714 (New Position) | View |
2019-12-06 4:53 pm Unchanged | 13D | CERECOR INC CERC | ARMISTICE CAPITAL LLC | 39,368,948 63.1% | 0 (Unchanged) | View |
2019-11-27 4:35 pm Purchase | 13G | BIO-PATH HLDGS INC PAR $0. BPTH | ARMISTICE CAPITAL LLC | 151,515 3.9% | 59,186 (+64.10%) | View |
2019-11-22 5:42 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | ARMISTICE CAPITAL LLC | 364,476 9.99% | 364,476 (New Position) | View |
2019-11-22 4:35 pm Purchase | 13D | VAXART INC VXRT | ARMISTICE CAPITAL LLC | 25,200,000 52.8% | 200,000 (+0.80%) | View |
2019-11-18 5:16 pm Purchase | 13D | RESHAPE LIFESCIENCES INC P RSLS | ARMISTICE CAPITAL LLC | 10,520,207 98.4% | 10,520,207 (New Position) | View |
2019-11-08 4:36 pm Purchase | 13G | TETRAPHASE PHARMACEUTICALS INC TTPH | ARMISTICE CAPITAL LLC | 327,447 9.99% | 327,447 (New Position) | View |
2019-11-07 4:19 pm Sale | 13D | AYTU BIOSCIENCE INC AYTU | ARMISTICE CAPITAL LLC | 8,378,692 40% | -1,372 (-0.02%) | View |